ZA885358B - Uricosuric composition - Google Patents

Uricosuric composition

Info

Publication number
ZA885358B
ZA885358B ZA885358A ZA885358A ZA885358B ZA 885358 B ZA885358 B ZA 885358B ZA 885358 A ZA885358 A ZA 885358A ZA 885358 A ZA885358 A ZA 885358A ZA 885358 B ZA885358 B ZA 885358B
Authority
ZA
South Africa
Prior art keywords
uricosuric
composition
gout
chem
drug
Prior art date
Application number
ZA885358A
Other languages
English (en)
Inventor
Mitsuyoshi Nakashima
Nakashima Mitsuyoshi
Mitsutaka Kanamaru
Kanamaru Mitsutaka
Akira Sugiyama
Sugiyama Akira
Masato Terakawa
Terakawa Masato
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of ZA885358B publication Critical patent/ZA885358B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA885358A 1987-07-29 1988-07-22 Uricosuric composition ZA885358B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18982287 1987-07-29

Publications (1)

Publication Number Publication Date
ZA885358B true ZA885358B (en) 1989-03-29

Family

ID=16247787

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA885358A ZA885358B (en) 1987-07-29 1988-07-22 Uricosuric composition

Country Status (8)

Country Link
US (1) US4931440A (fr)
EP (1) EP0301466B1 (fr)
KR (1) KR960014874B1 (fr)
AT (1) ATE95697T1 (fr)
AU (1) AU615932B2 (fr)
CA (1) CA1336959C (fr)
DE (1) DE3884878T2 (fr)
ZA (1) ZA885358B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0747582B2 (ja) * 1989-12-11 1995-05-24 杏林製薬株式会社 キナゾリン―３―アルカン酸誘導体とその塩およびその製造法
WO2000048447A2 (fr) * 1999-02-18 2000-08-24 R-Tech Ueno, Ltd. Composition pour le traitement de troubles de secretion externe a l'exception de l'hypolarmoiement

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524663D0 (en) * 1985-10-07 1985-11-13 Fujisawa Pharmaceutical Co Quinazoline derivatives

Also Published As

Publication number Publication date
EP0301466A2 (fr) 1989-02-01
US4931440A (en) 1990-06-05
CA1336959C (fr) 1995-09-12
KR960014874B1 (ko) 1996-10-21
EP0301466A3 (en) 1990-09-12
KR890001555A (ko) 1989-03-27
DE3884878D1 (de) 1993-11-18
EP0301466B1 (fr) 1993-10-13
DE3884878T2 (de) 1994-02-17
ATE95697T1 (de) 1993-10-15
AU615932B2 (en) 1991-10-17
AU2013888A (en) 1989-02-02

Similar Documents

Publication Publication Date Title
ES8707947A1 (es) Un procedimiento para la preparacion de acidos 3-hidroxifenoxialquilenheterociclilcarboxilicos.
NO163568C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
GR3005990T3 (fr)
PL289935A1 (en) Method of obtaining novel derivatives of 4h-pyrido-(1,2-a) pyrimidone-4
EP0640601A4 (fr) Derive de benzamide.
NO166938C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoxyeddiksyrederivater.
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
NO168243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO881835D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive bicykliske forbindelser.
DE69001722D1 (de) Entzuendungshemmende und/oder antiallergische zusammensetzung, die glutathionderivate enthaelt.
NO167737C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidazo(1,4)benzodiazepin-2-oner.
EP0270046A3 (en) Pharmaceutical composition for treatment of cataract
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
EP0301466A3 (en) Uricosuric composition
DK0420224T3 (da) Anthihepatopatisk middel
MY106235A (en) New 2 - carbonyl substituted n, n'' -di (trimethoxybenzoyl) piperazines, process for preparing the same and therapeutical compounds containing them.
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.